You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine

Citation Tools

Article menu

Download PDFPDF

Research Article
Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Wargowski E, Johnson LE, Eickhoff JC, et al
Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine
Journal for ImmunoTherapy of Cancer 2018;6:21. doi: 10.1186/s40425-018-0333-y